Dáil Éireann Debate, Wednesday - 18 May 2016
176. Deputy Billy Kelleher asked the Minister for Health the number of persons who participated on the trial Fampyra scheme for multiple sclerosis who are no longer having their costs covered on the grounds of not showing a sufficient improvement; and if he will make a statement on the matter. [10853/16]
Amharc ar fhreagraThe HSE has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013, therefore, the matter has been referred to the HSE for attention and direct reply to you.
If you have not received a reply from the HSE within 15 working days, please contact my Private Office and they will follow up the matter with them.
